IMB's latest news, explainers and more

 


Electric caterpillar sparks new venom discoveries

Read more

Get the latest research to your inbox

Subscribe
 

Imagine waking up every day wondering if you are going to have a 'good' or 'bad' pain day. That is the reality of more than 1 in 5 Australians who live with chronic pain. But what is chronic pain and how can we treat it?
  • Researchers will soon understand how to better target cancer treatments with the opening of a new Australian Cancer Research Foundation (ACRF) facility at The University of Queensland (UQ).
  • Evolution has shaped the human race, with University of Queensland researchers finding signatures of natural selection in the genome that influence traits associated with fertility and heart function.
  • Brisbane peptide research will be promoted internationally thanks to UQ researchers receiving an inaugural grant from the Lord Mayor.
  • In an age of growing antibiotic resistance, there is an urgent need to uncover new strategies to treat infectious disease. An emerging area of research (immunotherapy) aims to enhance the bodies’ own immune system to reduce reliance on traditional therapies. My research examines cells of the innate immune system (macrophages) and their interaction with bacteria (such as E. coli).
  • Bacteria are an important part of our microflora, but they can also cause disease. I study the molecular machines that are responsible for the correct formation of bacterial weapons.
  • Sepsis occurs when the body’s immune response to infection damages its own tissues. In severe cases, multiple organ failure can occur. If not treated promptly, the patient will die. Yet, we currently don't have reliable treatments for it. Our solution is to target the immune system itself. My PhD focuses on a machine in our cells that is important for recognising bacterial infection and recruiting immune responders. My goal is to discover how we can switch this machine on and off.
  • Research into sepsis, a devastating disease that is particularly dangerous for children and the elderly, has caught the imagination of Queenslanders, with a PhD student from The University of Queensland winning the 2018 Women in STEM Prize People’s Choice Award.
  • Epilepsy is the most common neurological disorder in children and it takes the form of recurring seizures. But epilepsy is not a single disease; rather, it is a diverse spectrum of disorders that comprise many types of seizures.
  • Reaching reproductive age is an important milestone, and for women this is usually marked by their first period. But for some young women, it never comes. In medical terms this is called primary amenorrhea, and one of the major causes is a congenital condition called Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome.

Pages

Strawberry DNA extraction activity

Extract and view DNA from a strawberry using common household ingredients.

Get started

 

The Edge: Infection

The latest research and discovery

We are tackling the problem of drug-resistant bacteria through developing new diagnostics and treatments, and by empowering the community with knowledge on how to fight back against the threat of superbugs.

 View the latest issue
 Download magazine

Do a PhD at IMB

Apply for the Global Challenges PhD Scholarship


We are training the next generation of researchers to tackle some of the most pressing global issues of our time.
Apply for the Domestic round and boost your stipend with our IMB Global Challenges Scholarship.
 

This year's theme is 'Drugs inspired by nature' where you can look to the world around us to develop new medicines.
Learn from the best see what you can achieve.

Find out more

Subscribe to our newsletter

Get the latest research straight to your inbox. 
Stay up-to-date as we answer questions about hot topics, and share the latest news at IMB, Australia’s #1 research institute.

Subscribe

General enquiries

  +61 7 3346 2222
  imb@imb.uq.edu.au

Media enquiries

IMB fully supports UQ's Reconciliation Action Plan and is implementing actions within our institute.

Support us

Donate to research
100% of donations go to the cause